The global incidence of dengue has been increasing rapidly, with significant impacts in major regions including Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific. The World Health Organization (WHO) reports a continuous rise in the number of dengue cases, highlighting the urgent need for effective diagnostic solutions.
This product will be delivered within 1-3 business days.
Rising Dengue Cases Across the Globe
Americas
In the Americas, the prevalence of dengue has reached alarming levels, with millions of reported cases. Brazil has emerged as a hotspot, contributing a substantial portion of these cases. The surge in dengue cases in Brazil is approximately three times higher than previously reported figures, underscoring the growing health crisis.Western Pacific Region
The Western Pacific region has also witnessed a significant number of suspected dengue cases. The Philippines and Malaysia are among the most affected countries, with both reporting a high number of cases. This escalating prevalence of dengue virus in these regions is driving the demand for diagnostic kits, which are crucial for timely and accurate detection.Climate Change and Dengue Fever
Impact of Climate Change
Climate change is exacerbating the prevalence of dengue fever worldwide. Recent outbreaks of dengue, chikungunya, and West Nile virus in previously unaffected countries highlight the potential threats posed by global warming. Changes in climate have heightened the current and future risks in various regions, including Europe. Altered climatic conditions have significantly impacted vector distribution and potential disease transmission.Environmental Factors
Environmental factors such as high rainfall and humidity create favorable breeding conditions for mosquitoes. Additionally, curtailed water supply and disrupted sanitation services facilitate mosquito proliferation, while warm temperatures extend the active season for these vectors. These climatic changes are likely to increase the burden of dengue fever, subsequently driving the growth of the dengue testing market.Innovations in Dengue Testing
Need for Cost-Effective Diagnostic Kits
Currently, the available diagnostic test kits for dengue are less effective, creating a need for cost-effective kits with high specificity and sensitivity. The high price and limited effectiveness of existing test kits have prompted companies to focus on developing reliable and affordable diagnostic methods. Increasing research and development activities aim to produce highly specific and sensitive diagnostic kits, opening new growth opportunities for manufacturers.Development of Point-of-Care Tests
Manufacturers are prioritizing the development of point-of-care tests that are rapid, sensitive, and easy to use. Many existing methods for detecting dengue virus rely on cell culture and mice inoculation, which are slow and expensive. There is a pressing need for rapid, user-friendly, and sensitive detection methods to enhance the efficiency of dengue diagnosis.Global Dengue Testing Market by Region
Dominance of Asia Pacific
The Asia Pacific region has been at the forefront of the global dengue testing market in terms of revenue. This trend is expected to continue, with Asia Pacific projected to remain the most attractive market for dengue testing. The region's significant share in the global dengue testing market underscores its critical role in addressing the dengue epidemic.Key Market Players Include:
- Abnova Corporation
- Roche Molecular Systems Inc.
- Abbott Laboratories
- InBios International, Inc.
- NovaTec Immundiagnostica GmbH
- Euroimmun AG (Sub. PerkinElmer)
- Quest Diagnostics
- Certest Biotec S.L.
- OriGene Technologies
- Thermo Fisher Scientific Inc.
- Others.
Global Dengue Testing Market Segmentation:
By Product Type:
- Premium
- Mid
- Low
By End User:
- Hospitals
- Public Health Laboratory
- Diagnostic Centers
- Others
By Region:
- China
- India
- Japan
- Indonesia
- South Korea
- Rest of Asia Pacific
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Dengue Testing Market Outlook, 2018 - 2031
4. North America Dengue Testing Market Outlook, 2018 - 2031
5. Europe Dengue Testing Market Outlook, 2018 - 2031
6. Asia Pacific Dengue Testing Market Outlook, 2018 - 2031
7. Latin America Dengue Testing Market Outlook, 2018 - 2031
8. Middle East & Africa Dengue Testing Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abnova Corporation
- Roche Molecular Systems Inc.
- Abbott Laboratories
- InBios International, Inc.
- NovaTec Immundiagnostica GmbH
- Euroimmun AG (Sub. PerkinElmer)
- Quest Diagnostics
- Certest Biotec S.L.
- OriGene Technologies
- Thermo Fisher Scientific Inc.
Methodology
LOADING...